Guidance document : regulatory requirements for drug identification numbers (DINs).: H164-273/2019E-1-PDF
"When Health Canada authorizes a drug to be marketed in Canada, a Drug Identification Number (DIN) is issued to the manufacturer and printed on the package labels. A DIN indicates that the evaluation of the drug determined that it met the relevant requirements of the Food and Drugs Act and its regulations and the drug has a favourable risk/benefit profile. Manufacturers of prescription and non‐prescription drugs must obtain a DIN before they are marketed in Canada. Market authorization of a drug may require the additional issuance of a Notice of Compliance (NOC)"--Introduction, page 8.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.874552&sl=0
| Department/Agency |
|
|---|---|
| Title | Guidance document : regulatory requirements for drug identification numbers (DINs). |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Later edition | Guidance document : [2021/06/28 edition] |
| Earlier edition | Guidance document : [2019/05/03 edition] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (28 pages) |
| ISBN | 9780660312880 |
| Catalogue number |
|
| Departmental catalogue number | 190110 |
| Edition |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: